U.S., Jan. 21 -- An application to own the trademark for 'GRAFALON' has been filed on Dec. 10, 2024.
Owner(s):
Neovii Biotech GmbH; Am Haag 6+7, 82116 Gräfelfing, GERMANY
Goods and/or Services:
For: Pharmaceutical compositions and preparations, namely, pharmaceutical preparations for the treatment of anti-neutrophil cytoplasmic antibody associated vasculitis, aplastic anemia, autoimmune diseases, diabetes, and for the prevention and treatment of graft-versus-host disease, hemophagocytic lymphohistiocytosis, lupus nephritis, multiple sclerosis, myelodysplastic syndrome, myelofibrosis, systemic lupus erythematosus, as well as for use in organ and tissue transplantation; biopharmaceutical compositions and preparations, in particular those ...